Immunotherapy in Melanoma: Where Are We Going From Here? @UCSFDepartmentofMedicine
Immunotherapy in Melanoma: Where Are We Going From Here?  @UCSFDepartmentofMedicine
Uploaded January 2026 | Updated September 2026, 2 weeks ago
Immunotherapy has transformed the treatment of melanoma. What's next in this quickly evolving field? This Grand Rounds will explore how immunotherapy agents work in melanoma and will highlight emerging molecules and innovative strategies shaping the next generation of melanoma treatment.

Adil Daud, MD, is professor of medicine in the Division of Hematology and Oncology at UCSF Health and co-director of the UCSF Helen Diller Family Comprehensive Cancer Center Melanoma Program. His research focuses on cancer immunotherapy, particularly in skin cancers and site-specific immunity. He has designed and conducted clinical trials related to melanoma treatment and has developed novel immunotherapies to treat this cancer.

Program:
Allison Bond: Introduction
0:47-48:42 — Adil Daud
48:43-1:00:26 — Q&A

See previous Medical Grand Rounds:

January 6: Metagenomic Next-Generation Sequencing: Updates on A Cutting-Edge Diagnostic Tool
youtu.be/Zq9At7E6PnM
December 9: Beyond the Scale: Harnessing Anti-Obesity Medications to Treat Obesity and its Complications
youtu.be/BBY0-1RVvMk
December 2: The Rudi Schmid Lecture: A Cure for Hepatitis C: Now What?
youtu.be/V4NOnT4qf-A
November 18: Hollander Rounds: A Clinical Problem-Solving Case
youtu.be/E6zuN1Tm0DQ
Immunotherapy in Melanoma: Where Are We Going From Here?UCSF Rheumatology Fellowship ProgramUnlocking the Mysteries of Long COVIDCommunity-Engaged Climate Change Solutions: Exposure Science and Intervention ResearchClimbing to New Heights in Lung Transplantation: Surgical & Medical Innovations to Improve OutcomesMetagenomic Next-Generation Sequencing: Updates on A Cutting-Edge Diagnostic ToolGenerative AI in the DOM: Cutting-Edge Applications and InnovationsStem Cell Transplants and Emerging Cellular Therapies for Cancer: Challenges and OpportunitiesHealthcare for the Underserved — What’s Roe Got to Do with It?International Women’s DayUpdates in the Diagnosis and Management of DeliriumLoneliness and Social Isolation Among Older Adults: The Role of Clinicians with Ashwin Kotwal
UCSF Department of Medicine |

Immunotherapy in Melanoma: Where Are We Going From Here?

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER